AI Bubble Fears Trigger a Surprising Shift to Swiss Stocks

Have you noticed how quickly the mood in the financial markets can change? For months, almost every headline seemed to focus on the relentless rise of artificial intelligence. Tech giants were driving major stock indexes to record highs, and investors everywhere appeared eager to grab a piece of the AI boom.

However, a noticeable shift recently took place across European equity markets. Instead of continuing to chase high-flying tech names, global investors quietly turned their attention toward battle-tested Swiss stocks, creating an unusual divergence in performance across European indices.

Swiss Stocks Outperform European Peers

During October, the Swiss Market Index (SMI) surged by 4.6%. In contrast, the Euro Stoxx 50—which tracks 50 of the largest companies across the euro area—dropped by 3.2% over the same period.

This performance split created an almost 8 percentage point gap between Swiss blue chips and their broader European counterparts. To put that into perspective, this represents the widest performance gap between these two landmark indices since March 2020.

Three Key Drivers Behind the Market Shift

Why are fund managers suddenly directing capital into Zurich? According to analysis highlighted by Bloomberg, three major economic pressures have prompted investors to reduce risk across European equity markets:

• Rising Borrowing Costs: Persistent interest rate pressures have made debt financing more expensive for growth-focused firms.
• Growing AI Doubts: Market participants are reassessing whether massive capital investments in AI will deliver expected returns in the near term.
• Political Turmoil: Ongoing political uncertainties in major European economies like France and Spain have led investors to seek more stable markets.

Three Giants Power the Swiss Market Index

A closer look at the Swiss market shows that the October gains were not evenly spread across every listed company. Instead, three massive corporate giants generated the entire gain for the Swiss Market Index:

• Roche: The pharmaceutical leader climbed 12% during October.
• Novartis: The healthcare titan added 6.7% over the same month.
• Nestlé: The global food and beverage heavyweight rose 10%.

Together, these three companies represent nearly half of the SMI's total market capitalization. As a result, tracking or buying into the SMI today essentially acts as a concentrated position in these three healthcare and consumer staples powerhouses.

Why Defensive Assets Are Back in Favor

Companies like Nestlé, Roche, and Novartis are classic examples of defensive stocks. Regardless of economic downturns or fluctuations in interest rates, demand for essential prescription medications, medical treatments, and daily food items remains relatively stable.

When financial markets face elevated borrowing costs or heightened economic uncertainty, businesses with steady revenues and strong balance sheets tend to attract risk-averse institutional capital.

The AI Pullback and Tightening Credit Markets

The rotation into Swiss equities unfolded alongside a significant pull-back in global artificial intelligence and semiconductor shares. According to data reported by CNBC, 20 of the top AI and chip stocks collectively lost over $1 trillion in market capitalization between October 12 and October 15.

Investors began raising concerns that sustained high borrowing costs could lead tech firms to scale back capital expenditure on AI infrastructure. Reflecting these elevated debt costs, global corporate bond spreads expanded to their widest levels since May 2025.

"Investors like the defensiveness of Swiss stocks and are actively looking for alternatives to the crowded AI trades. Healthcare was the funding sector for the AI trade, and that is reversing now," noted Damian Burkhardt, Portfolio Manager at EFG Asset Management.

Fund Manager Positioning and Market Valuations

Survey data from Bank of America (BofA) emphasizes how heavily weighted investors were toward tech prior to this market correction. The global fund manager survey conducted between October 2 and October 8 showed that allocations to technology stocks had reached their highest levels since August 2020.

In BofA's regional survey for Europe, Switzerland placed joint second among favored stock destinations with a net 16% overweight allocation, behind Spain's net 28%.

What Lies Ahead for Investors?

While the capital flight into Swiss blue-chip stocks provided a strong cushion for equity portfolios in October, it has also pushed up valuations for these defensive giants. As Swiss equities become more expensive relative to their historic multiples, analysts are watching closely to see how far this rotation can extend.

Past performance of stock market indices or individual assets is not an indicator of future results. Investors should continue monitoring macro interest rate trends, corporate earnings updates, and global bond yields when navigating market movements.